Quantcast

Latest Liver transplantation Stories

2014-07-28 04:21:40

HORSHOLM, Denmark, July 28, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus(®) for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union (EU). Key points:

2014-07-14 12:27:15

Special happenings at this year's event: liver recipient meets her donor's family for the first time, baseball legend Vinny Castilla hosts children's area DENVER, July 14, 2014 /PRNewswire/ -- One of Denver's most celebrated and attended cause-related 5Ks, the Donor Dash, is celebrating 15 years this summer. Taking place July 20 in Denver's historic Washington Park, the Donor Dash is a run/walk to honor the lives of organ, eye and tissue donors, celebrate the lives of recipients and...

2014-07-11 12:24:32

Hospital successfully transplants the first liver dialysis patient in the state HOUSTON, July 11, 2014 /PRNewswire-USNewswire/ -- Texas Children's Hospital is excited to announce the first use of an extracorporeal liver support therapy in Texas for children with acute liver failure. The hospital now offers the Molecular Adsorbent Recirculating System (MARS®), a liver dialysis therapy, which helped a 9-year-old patient with hepatic coma become healthy enough to be a candidate for...

2014-07-06 23:02:18

A team of doctors at Sir Ganga Ram Hospital, New Delhi consisting of Dr. Suresh Singhvi (Senior Consultant Hepatic & Pancreatic Surgery and Liver Transplant) and Dr. Sujay Shad (Senior Cardiac Surgeon) performed a rare surgery on a Nigerian patient, who had cancer of the liver that had spread to the heart. The patient reported to the hospital for a follow-up 15 months after the surgery and has recovered completely. New Delhi, India (PRWEB) July 06, 2014 Dr. Lubabatuyakuba Musa, a...

2014-06-28 13:57:32

TUM Virus infection supports organ acceptance Chronic hepatitis C virus infections are among the most common reasons for liver transplants. Because existing viruses also infect the new liver, the immune system is highly active there. Despite this, the new organ is not rejected, as scientists from the Helmholtz Zentrum München and the Technische Universität München (TUM) have now discovered. The long-term stimulation of the innate immune system by the virus actually increases the...

Hepatitis C treatment debate
2014-06-23 05:10:27

redOrbit Staff & Wire Reports - Your Universe Online A new combination therapy could cut treatment time for hepatitis C to just four weeks, but quicker recovery comes with a steep price, as the new medication is said to cost roughly $1,000 per pill. According to Reuters reporter Bill Berkrot, the treatment involves an experimental antiviral drug produced by Bristol-Myers Squibb and Sovaldi, a drug produced by Gilead Sciences Inc. that has reportedly outraged insurance companies and...

2014-05-29 08:29:58

SMIC and Renji Hospital holds The Children's Day Liver Transplant charity event SHANGHAI, May 29, 2014 /PRNewswire/ -- Semiconductor Manufacturing International Corporation ("SMIC"; NYSE: SMI; SEHK: 981), China's largest and most advanced semiconductor foundry, announced the donation of an additional 2 million yuan (including staff donations) to the Soong Ching Ling Foundation to help fund the SMIC Liver Transplant Program for Children. The announcement was made during The Children's...

2014-05-22 04:21:28

HORSHOLM, Denmark, May 22, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Envarsus® for the prevention of organ rejection in adult transplant patients in the European Union (EU). The positive opinion is for both kidney and liver transplant recipients and includes both the...

2014-05-12 08:31:08

DUBLIN and SAN DIEGO, May 12, 2014 /PRNewswire/ -- - Acquisition of Lumena Pharmaceuticals, a biopharmaceutical company with late stage rare disease pipeline assets - Adds to Shire's rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire's already strong Gastrointestinal (GI) presence - Adds LUM001 in Phase 2 development for four rare and devastating hepatic diseases, two...

2014-05-03 16:21:30

CINCINNATI, May 3, 2014 /PRNewswire-USNewswire/ -- A multi-center study concludes that treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia and leads to earlier onset of serious adverse events. http://photos.prnewswire.com/prnvar/20110406/MM79025LOGO Researchers say the clinical trial involving 14 sites provides new evidence on a growing controversy in the medical community - whether treating infants...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related